Bevacizumab in Combination with Modified FOLFOX6 in Heavily Pretreated Patients with HER2/Neu-Negative Metastatic Breast Cancer: A Phase II Clinical Trial

Bevacizumab in Combination with Modified FOLFOX6 in Heavily Pretreated Patients with HER2/Neu-Negative Metastatic Breast Cancer: A Phase II Clinical Trial

Bibliographic Details
Main Authors: Li, Ting, Wang, Biyun, Wang, Zhonghua, Ragaz, Joseph, Zhang, Jian, Sun, Si, Cao, Jun, Lv, Fangfang, Wang, Leiping, Zhang, Sheng, Ni, Chen, Wu, Zhenhua, Xie, Jie, Hu, Xichun
Format: Online
Language:English
Published: Public Library of Science 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506015/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506015/

Similar Items